FDA Approves Sexual Desire Drug for Postmenopausal Women

By News Health
2 months Ago

(MedPage Today) — The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
Flibanserin is a mixed 5-HT1A…

Source link : https://www.medpagetoday.com/obgyn/menopause/119031

Author :

Publish date : 2025-12-15 22:41:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Reimagining Asthma Care: The Evolving Landscape of Maintenance Treatment

Doctors Urged to Ask About Herbal Remedies

Jesse Jackson Dies; CDC Acting Director Exits; NIAID Scrubs Websites

At Discharge, Patients’ Medication Lists Rarely Shrink

The Coming Age of Genetic Doping in Olympic Sport

The Case for Continuous Glucose Monitoring in Pregnancy